A Randomized Trial of Methadone Initiation Prior to Release from Incarceration (original) (raw)

Effect of methadone treatment on incarceration rates among injection drug users

Daniel Werb

2008

View PDFchevron_right

Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection

Kate Dolan, Bethany White

Addiction, 2005

View PDFchevron_right

A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release

Michael Gordon

Addiction, 2008

View PDFchevron_right

Methadone dose at the time of release from prison significantly influences retention in treatment: Implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia

Marwan Azar

Drug and Alcohol Dependence, 2013

View PDFchevron_right

Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection

ALI METHADONE

Journal of general …, 2006

View PDFchevron_right

Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users

David Marsh

Addiction, 2010

View PDFchevron_right

Drug use, HIV-related risk behaviors and dropout status of new admissions and re-admissions to methadone treatment

Sherry Deren, Peter Flom

Journal of Substance Abuse Treatment, 2001

View PDFchevron_right

Randomized trial of methadone treatment of arrestees: 24-month post-release outcomes

Tiffany Duren

Drug and Alcohol Dependence, 2021

View PDFchevron_right

Methadone maintenance treatment reduces heroin injection in New South Wales prisons

Wayne Hall

Drug and Alcohol Review, 1998

View PDFchevron_right

Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program

Margaret Millson, Carol Strike

AIDS Education & …, 2007

View PDFchevron_right

Methadone Maintenance vs 180-Day Psychosocially Enriched Detoxification for Treatment of Opioid Dependence

yudi Prasetyo

JAMA, 2000

View PDFchevron_right

Design and implementation of a factorial randomized controlled trial of methadone maintenance therapy and an evidence-based behavioral intervention for incarcerated people living with HIV and opioid dependence in Malaysia

Veena Pillai

Contemporary clinical trials, 2017

View PDFchevron_right

The Impact of Methadone Maintenance Treatment on HIV Risk Behaviors among High-Risk Injection Drug Users: A Systematic Review

Pramila Karki

Evidence-based Medicine & Public Health, 2018

View PDFchevron_right

Methadone maintenance program for AIDS-affected opiate addicts

Steven Batki

Journal of Substance Abuse Treatment, 1989

View PDFchevron_right

Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus

David Celentano

AIDS, 2000

View PDFchevron_right

Impact of incarceration on rates of methadone use in a community recruited cohort of injection drug users

John Koehn, Launette M . Rieb

Addiction Science and Clinical Practice, 2015

View PDFchevron_right

Incarceration and Opioid Withdrawal: The Experiences of Methadone Patients and Out-of-Treatment Heroin Users

James A Peterson

Journal of Psychoactive Drugs, 2009

View PDFchevron_right

Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency

Howard Rhoades

American Journal of Public Health, 1998

View PDFchevron_right

Association of Methadone Treatment With Substance-Related Hospital Admissions Among a Population in Canada With a History of Criminal Convictions

Julian M Somers

JAMA Network Open

View PDFchevron_right

A pilot survey of attitudes and knowledge about opioid substitution therapy for HIV-infected prisoners

Sandra Springer

Journal of opioid management

View PDFchevron_right

Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community

Frederick Altice

Contemporary clinical trials, 2014

View PDFchevron_right

Extended-Release Naltrexone Improves Viral Suppression among Incarcerated Persons Living with HIV with Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial

Sandra Springer

Journal of acquired immune deficiency syndromes (1999), 2018

View PDFchevron_right

Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics

Karina Berg

Contemporary Clinical Trials, 2009

View PDFchevron_right

A randomized trial of an interim methadone maintenance clinic

Joshua Robinson

American Journal of Public Health, 1991

View PDFchevron_right

Association of patterns of methadone use with antiretroviral therapy discontinuation: a prospective cohort study

Paxton Bach

BMC infectious diseases, 2015

View PDFchevron_right

Impact of methadone treatment initiated in jail on subsequent arrest

Tiffany Duren

Journal of Substance Abuse Treatment, 2020

View PDFchevron_right

Methamphetamine use drives decreases in viral suppression for people living with HIV released from a large municipal jail: Results of the LINK LA clinical trial

Wendy Garland

Drug and Alcohol Dependence, 2019

View PDFchevron_right

Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial

Shannon Mitchell

Contemporary clinical trials, 2016

View PDFchevron_right

Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial

Manasa Reddy

Lancet, 2015

View PDFchevron_right